Molecular Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention Chemical and Biological Aspects of Inflammation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, B.-C.
Right arrow Articles by Avraham, H. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, B.-C.
Right arrow Articles by Avraham, H. K.
Molecular Cancer Research 2:327-338 (2004)
© 2004 American Association for Cancer Research


Angiogenesis, Metastasis, and the Cellular Microenvironment

Involvement of the Chemokine Receptor CXCR4 and Its Ligand Stromal Cell-Derived Factor 1{alpha} in Breast Cancer Cell Migration Through Human Brain Microvascular Endothelial Cells1

Byeong-Chel Lee, Tae-Hee Lee, Shalom Avraham and Hava Karsenty Avraham

Division of Experimental Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts

Requests for reprints: Hava Karsenty Avraham, Division of Experimental Medicine, Beth Israel Deaconess Medical Center, Harvard Institutes of Medicine, 4 Blackfan Circle, Boston, MA 02115. Phone: (617) 667-0073; Fax: (617) 975-6373. E-mail: havraham{at}bidmc.harvard.edu

In this study, we have characterized the signaling pathways mediated by CXCR4 in breast cancer cells and its role in breast cancer cell invasion and migration. Stromal cell-derived factor 1{alpha} (SDF-1{alpha}; CXCL12) stimulation of breast cancer cells resulted in phosphoinositide 3-kinase (PI-3K) activation, AKT phosphorylation, and activation of the FKHRL1 transcription factor. In addition, SDF-1{alpha} induced activation of the focal adhesion kinase (FAK) as well as the migration of breast cancer cells. Expression of SDF-1{alpha}, the ligand of CXCR4, was about 2-fold higher in microdissected human breast epithelial cancer cells as compared with normal epithelial cells. Immunohistochemical analysis indicated that SDF-1{alpha} expression is consistently higher in primary breast tumor cells than in normal breast epithelial cells. Furthermore, SDF-1{alpha} induced blood vessel instability, through increased vascular permeability, resulting in the penetration of breast tumor cells through the human brain microvascular endothelial cells (HBMEC). Notably, the migration of breast cancer cells was inhibited by the PI-3K inhibitor, Wortmannin, and the Ca2+ inhibitor BAPTA/AM, indicating that transendothelial breast cancer cell migration induced by SDF-1{alpha} is mediated by activation of the PI-3K/AKT pathway and Ca2+-mediated signaling. Blockade of the CXCR4/SDF1 signaling pathway with anti-CXCR4 antibody also decreased transendothelial breast cancer cell migration as well as vascular permeability. This study focuses on novel interactions between highly relevant signaling pathways in breast cancer cells and brain microvascular endothelial cells and may provide insights into the molecular mechanisms of CXCR4/SDF-1{alpha}-mediated breast cancer metastasis to the brain.

Key Words: SDF-1{alpha} • CXCR4 • migration • signaling • metastasis • breast cancer




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. O. Rehman and C.-Y. Wang
SDF-1{alpha} Promotes Invasion of Head and Neck Squamous Cell Carcinoma by Activating NF-{kappa}B
J. Biol. Chem., July 18, 2008; 283(29): 19888 - 19894.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
N Cabioglu, Y Gong, R Islam, K. Broglio, N Sneige, A Sahin, A. Gonzalez-Angulo, P Morandi, C Bucana, G. Hortobagyi, et al.
Expression of growth factor and chemokine receptors: new insights in the biology of inflammatory breast cancer
Ann. Onc., June 1, 2007; 18(6): 1021 - 1029.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Wysoczynski, K. Miekus, K. Jankowski, J. Wanzeck, S. Bertolone, A. Janowska-Wieczorek, J. Ratajczak, and M. Z. Ratajczak
Leukemia Inhibitory Factor: A Newly Identified Metastatic Factor in Rhabdomyosarcomas
Cancer Res., March 1, 2007; 67(5): 2131 - 2140.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. R. Harvey, P. Mellor, H. Eldaly, T. W.J. Lennard, J. A. Kirby, and S. Ali
Inhibition of CXCR4-Mediated Breast Cancer Metastasis: A Potential Role for Heparinoids?
Clin. Cancer Res., March 1, 2007; 13(5): 1562 - 1570.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
Z. Gabos, R. Sinha, J. Hanson, N. Chauhan, J. Hugh, J. R. Mackey, and B. Abdulkarim
Prognostic Significance of Human Epidermal Growth Factor Receptor Positivity for the Development of Brain Metastasis After Newly Diagnosed Breast Cancer
J. Clin. Oncol., December 20, 2006; 24(36): 5658 - 5663.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
R. J. Weil, D. C. Palmieri, J. L. Bronder, A. M. Stark, and P. S. Steeg
Breast Cancer Metastasis to the Central Nervous System
Am. J. Pathol., October 1, 2005; 167(4): 913 - 920.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
N. Cabioglu, M. S. Yazici, B. Arun, K. R. Broglio, G. N. Hortobagyi, J. E. Price, and A. Sahin
CCR7 and CXCR4 as Novel Biomarkers Predicting Axillary Lymph Node Metastasis in T1 Breast Cancer
Clin. Cancer Res., August 15, 2005; 11(16): 5686 - 5693.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Cabioglu, J. Summy, C. Miller, N. U. Parikh, A. A. Sahin, S. Tuzlali, K. Pumiglia, G. E. Gallick, and J. E. Price
CXCL-12/Stromal Cell-Derived Factor-1{alpha} Transactivates HER2-neu in Breast Cancer Cells by a Novel Pathway Involving Src Kinase Activation
Cancer Res., August 1, 2005; 65(15): 6493 - 6497.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. Guleng, K. Tateishi, M. Ohta, F. Kanai, A. Jazag, H. Ijichi, Y. Tanaka, M. Washida, K. Morikane, Y. Fukushima, et al.
Blockade of the Stromal Cell-Derived Factor-1/CXCR4 Axis Attenuates In vivo Tumor Growth by Inhibiting Angiogenesis in a Vascular Endothelial Growth Factor-Independent Manner
Cancer Res., July 1, 2005; 65(13): 5864 - 5871.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B.-C. Lee, T.-H. Lee, R. Zagozdzon, S. Avraham, A. Usheva, and H. K. Avraham
Carboxyl-Terminal Src Kinase Homologous Kinase Negatively Regulates the Chemokine Receptor CXCR4 through YY1 and Impairs CXCR4/CXCL12 (SDF-1{alpha})-Mediated Breast Cancer Cell Migration
Cancer Res., April 1, 2005; 65(7): 2840 - 2845.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.